Atosiban

Tractocile (atosiban) is a protein pharmaceutical. Atosiban was first approved as Tractocile on 2000-01-20. It has been approved in Europe to treat premature birth. It is known to target vasopressin V1b receptor, vasopressin V1a receptor, oxytocin receptor, and vasopressin V2 receptor.